230 related articles for article (PubMed ID: 30588243)
1. Decoding Somatic Driver Gene Mutations and Affected Signaling Pathways in Human Medulloblastoma Subgroups.
Robbins CJ; Bou-Dargham MJ; Sanchez K; Rosen MC; Sang QA
J Cancer; 2018; 9(24):4596-4610. PubMed ID: 30588243
[TBL] [Abstract][Full Text] [Related]
2. Sex differences in methylation profiles are apparent in medulloblastoma, particularly among SHH tumors.
Moss RM; Sorajja N; Mills LJ; Moertel CL; Hoang TT; Spector LG; Largaespada DA; Williams LA
Front Oncol; 2023; 13():1113121. PubMed ID: 37035203
[TBL] [Abstract][Full Text] [Related]
3. Subgroup-specific prognostic signaling and metabolic pathways in pediatric medulloblastoma.
Park AK; Lee JY; Cheong H; Ramaswamy V; Park SH; Kool M; Phi JH; Choi SA; Cavalli F; Taylor MD; Kim SK
BMC Cancer; 2019 Jun; 19(1):571. PubMed ID: 31185958
[TBL] [Abstract][Full Text] [Related]
4. Long Noncoding RNAs: Emerging Players in Medulloblastoma.
Laneve P; Rea J; Caffarelli E
Front Pediatr; 2019; 7():67. PubMed ID: 30923703
[TBL] [Abstract][Full Text] [Related]
5. MRI features as a helpful tool to predict the molecular subgroups of medulloblastoma: state of the art.
Colafati GS; Voicu IP; Carducci C; Miele E; Carai A; Di Loreto S; Marrazzo A; Cacchione A; Cecinati V; Tornesello A; Mastronuzzi A
Ther Adv Neurol Disord; 2018; 11():1756286418775375. PubMed ID: 29977341
[TBL] [Abstract][Full Text] [Related]
6. Epigenetic Drivers in Pediatric Medulloblastoma.
Roussel MF; Stripay JL
Cerebellum; 2018 Feb; 17(1):28-36. PubMed ID: 29178021
[TBL] [Abstract][Full Text] [Related]
7. Methylation Profiling of Medulloblastoma in a Clinical Setting Permits Sub-classification and Reveals New Outcome Predictions.
Alharbi M; Mobark N; Bashawri Y; Abu Safieh L; Alowayn A; Aljelaify R; AlSaeed M; Almutairi A; Alqubaishi F; AlSolme E; Ahmad M; Al-Banyan A; Alotabi FE; Serrano J; Snuderl M; Al-Rashed M; Abedalthagafi M
Front Neurol; 2020; 11():167. PubMed ID: 32265819
[TBL] [Abstract][Full Text] [Related]
8. FSTL5 is a marker of poor prognosis in non-WNT/non-SHH medulloblastoma.
Remke M; Hielscher T; Korshunov A; Northcott PA; Bender S; Kool M; Westermann F; Benner A; Cin H; Ryzhova M; Sturm D; Witt H; Haag D; Toedt G; Wittmann A; Schöttler A; von Bueren AO; von Deimling A; Rutkowski S; Scheurlen W; Kulozik AE; Taylor MD; Lichter P; Pfister SM
J Clin Oncol; 2011 Oct; 29(29):3852-61. PubMed ID: 21911727
[TBL] [Abstract][Full Text] [Related]
9. [Identification of a Family with SUFU Germline Deletion Based on a Case of Desmoplastic Medulloblastoma in an Infant].
Šoukalová J; Vejmělková K; Cermanová T; Kašíková K; Mikulášová A; Janyšková H; Melichárková K; Pavelka Z; Ježová M; Pospíšilová Š; Kuglík P; Valášková I; Gaillyová R; Štěrba J; Zitterbart K
Klin Onkol; 2016; 29 Suppl 1():S83-8. PubMed ID: 26691947
[TBL] [Abstract][Full Text] [Related]
10. Epigenetic regulation in medulloblastoma.
Yi J; Wu J
Mol Cell Neurosci; 2018 Mar; 87():65-76. PubMed ID: 29269116
[TBL] [Abstract][Full Text] [Related]
11. A Novel Method for Rapid Molecular Subgrouping of Medulloblastoma.
Gómez S; Garrido-Garcia A; Garcia-Gerique L; Lemos I; Suñol M; de Torres C; Kulis M; Pérez-Jaume S; Carcaboso ÁM; Luu B; Kieran MW; Jabado N; Kozlenkov A; Dracheva S; Ramaswamy V; Hovestadt V; Johann P; Jones DTW; Pfister SM; Morales La Madrid A; Cruz O; Taylor MD; Martin-Subero JI; Mora J; Lavarino C
Clin Cancer Res; 2018 Mar; 24(6):1355-1363. PubMed ID: 29351917
[No Abstract] [Full Text] [Related]
12. The whole-genome landscape of medulloblastoma subtypes.
Northcott PA; Buchhalter I; Morrissy AS; Hovestadt V; Weischenfeldt J; Ehrenberger T; Gröbner S; Segura-Wang M; Zichner T; Rudneva VA; Warnatz HJ; Sidiropoulos N; Phillips AH; Schumacher S; Kleinheinz K; Waszak SM; Erkek S; Jones DTW; Worst BC; Kool M; Zapatka M; Jäger N; Chavez L; Hutter B; Bieg M; Paramasivam N; Heinold M; Gu Z; Ishaque N; Jäger-Schmidt C; Imbusch CD; Jugold A; Hübschmann D; Risch T; Amstislavskiy V; Gonzalez FGR; Weber UD; Wolf S; Robinson GW; Zhou X; Wu G; Finkelstein D; Liu Y; Cavalli FMG; Luu B; Ramaswamy V; Wu X; Koster J; Ryzhova M; Cho YJ; Pomeroy SL; Herold-Mende C; Schuhmann M; Ebinger M; Liau LM; Mora J; McLendon RE; Jabado N; Kumabe T; Chuah E; Ma Y; Moore RA; Mungall AJ; Mungall KL; Thiessen N; Tse K; Wong T; Jones SJM; Witt O; Milde T; Von Deimling A; Capper D; Korshunov A; Yaspo ML; Kriwacki R; Gajjar A; Zhang J; Beroukhim R; Fraenkel E; Korbel JO; Brors B; Schlesner M; Eils R; Marra MA; Pfister SM; Taylor MD; Lichter P
Nature; 2017 Jul; 547(7663):311-317. PubMed ID: 28726821
[TBL] [Abstract][Full Text] [Related]
13. Clinical implications of medulloblastoma subgroups: incidence of CSF diversion surgery.
Schneider C; Ramaswamy V; Kulkarni AV; Rutka JT; Remke M; Tabori U; Hawkins C; Bouffet E; Taylor MD
J Neurosurg Pediatr; 2015 Mar; 15(3):236-42. PubMed ID: 25525930
[TBL] [Abstract][Full Text] [Related]
14. β-arrestin1-mediated acetylation of Gli1 regulates Hedgehog/Gli signaling and modulates self-renewal of SHH medulloblastoma cancer stem cells.
Miele E; Po A; Begalli F; Antonucci L; Mastronuzzi A; Marras CE; Carai A; Cucchi D; Abballe L; Besharat ZM; Catanzaro G; Infante P; Di Marcotullio L; Canettieri G; De Smaele E; Screpanti I; Locatelli F; Ferretti E
BMC Cancer; 2017 Jul; 17(1):488. PubMed ID: 28716052
[TBL] [Abstract][Full Text] [Related]
15. p53 Function Is Compromised by Inhibitor 2 of Phosphatase 2A in Sonic Hedgehog Medulloblastoma.
Wei Y; Maximov V; Morrissy SA; Taylor MD; Pallas DC; Kenney AM
Mol Cancer Res; 2019 Jan; 17(1):186-198. PubMed ID: 30224541
[TBL] [Abstract][Full Text] [Related]
16. Molecular Classification of Medulloblastoma.
Kijima N; Kanemura Y
Neurol Med Chir (Tokyo); 2016 Nov; 56(11):687-697. PubMed ID: 27238212
[TBL] [Abstract][Full Text] [Related]
17. Medulloblastoma therapy generates risk of a poorly-prognostic H3 wild-type subgroup of diffuse intrinsic pontine glioma: a report from the International DIPG Registry.
Gits HC; Anderson M; Stallard S; Pratt D; Zon B; Howell C; Kumar-Sinha C; Vats P; Kasaian K; Polan D; Matuszak M; Spratt DE; Leonard M; Qin T; Zhao L; Leach J; Chaney B; Escorza NY; Hendershot J; Jones B; Fuller C; Leary S; Bartels U; Bouffet E; Yock TI; Robertson P; Mody R; Venneti S; Chinnaiyan AM; Fouladi M; Gottardo NG; Koschmann C
Acta Neuropathol Commun; 2018 Jul; 6(1):67. PubMed ID: 30049282
[TBL] [Abstract][Full Text] [Related]
18. Molecular markers and potential therapeutic targets in non-WNT/non-SHH (group 3 and group 4) medulloblastomas.
Menyhárt O; Giangaspero F; Győrffy B
J Hematol Oncol; 2019 Mar; 12(1):29. PubMed ID: 30876441
[TBL] [Abstract][Full Text] [Related]
19. Molecular Heterogeneity and Cellular Diversity: Implications for Precision Treatment in Medulloblastoma.
Zou H; Poore B; Broniscer A; Pollack IF; Hu B
Cancers (Basel); 2020 Mar; 12(3):. PubMed ID: 32164294
[TBL] [Abstract][Full Text] [Related]
20. Molecular Determinants of Medulloblastoma Metastasis and Leptomeningeal Dissemination.
Li M; Deng Y; Zhang W
Mol Cancer Res; 2021 May; 19(5):743-752. PubMed ID: 33608450
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
